Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 8th April 2015
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Joint strategy to benefit human and animal health
Syringe
The document under consultation outlines joint key priorities for the network.

Draft document outlines priorities for next five years

The European Medicines Agency (EMA) and Heads of Medicines Agencies (HMA) have released the 'EU Medicines Agencies Network Strategy to 2020'.

The document focuses on areas where collaboration within the network can make a difference to human and animal health in Europe in the next five years.

It is presented, for the first time, as a single strategy for the entire network - reflecting the need for a coordinated approach.

Arranged under four key themes, the strategy focusses on:

  • Human health
  • Animal and human health in relation to veterinary medicines,
  • Optimising the operation of the network
  • The global regulatory environment
It also includes a high level strategy to achieve these priorities.  

EMA and HMA say that the need to further strengthen the collaboration between the members of the network and work together towards achieving agreed goals has become more urgent in recent years.

"Europe faces the global threat of antibiotic resistance, and needs to be prepared for emerging epidemics," a spokesperson said.  "At the same time, the healthcare needs of patients in Europe are changing.  

"Advancements in science and medicine mean that new and more complex medicines are being developed, which may bring opportunities for personalised medicines and more treatments for rare diseases. Patients also require timely access to new, beneficial and safe medicines.

"The globalisation of the pharmaceutical industry means that greater collaboration with regulators beyond the European Union (EU) is essential to assure the supply of safe, effective and good quality medicines for humans and animals."

To view the Strategy visit www.ema.europa.eu. Stakeholders are invited to send their comments to EUnetworkstrategy@ema.europa.eu by 30 June 2015.

Become a member or log in to add this story to your CPD history

Animal Medicines Amnesty returns this November

News Story 1
 Veterinary practices are being urged to help owners safely dispose of any unused and expired pet medicines - not just antibiotics - during November's Animal Medicines Amnesty.

Organised by the Responsible Use of Medicines Alliance Companion Animal and Equine (RUMA CA&E), the initative is supported by a range of cross-sector organisations.

Practices are encouraged to use the campaign to engage the whole practice team and raise awareness of the safe disposal of medicines with clients. Learn how your practice can get involved at rumacae.org.uk 

Click here for more...
News Shorts
APHA launches free virtual work experience programme

The Animal and Plant Health Agency (APHA), in collaboration with Springpod, has launched a free virtual work experience programme, giving young people across the UK the chance to explore careers dedicated to protecting animal and plant health.

The on-demand programme offers a unique insight into career opportunities within APHA, showcasing how students can contribute to tackling some of the UK's most critical biosecurity and environmental challenges.

Designed for students aged 13 and over, the course includes more than 10 hours of engaging content featuring real-life industry insights, scenario-based challenges, and practical guidance on applying for jobs. To register for the course, visit the APHA website.